Table 4. Summary of the results of differences of change scores of GAD-7a at 52 weeks using MMRMb CBTc components, week, CBT component by week interaction, university, age, and baseline scores as fixed effects, while participants were introduced as a random effect. Effect size was estimated by division of the estimated mean changes by the observed SD of baseline scores.
Component | Participants, n | Estimated least squares mean change scores of GAD-7 within groups (95% CI) | Within-group effect size for baseline-week 52 change score of GAD-7 (95% CI) | Estimated differences of baseline-week 52 change scores between groups (95% CI) | Effect size for differences of baseline-week 52 change scores between groups (95% CI) | P values | |
SM d | 0.27 (−0.46 to 1) | 0.08 (−0.14 to 0.3) | .47 | ||||
Presence | 808 | −1.28 (−1.82 to −0.74) | −0.38 (−0.55 to −0.22) | ||||
Absence | 818 | −1.55 (−2.08 to −1.02) | −0.47 (−0.62 to −0.31) | ||||
BA e | −0.32 (−1.04 to 0.41) | −0.09 (−0.31 to 0.12) | .39 | ||||
Presence | 817 | −1.57 (−2.11 to −1.04) | −0.47 (−0.63 to −0.31) | ||||
Absence | 809 | −1.26 (−1.79 to −0.72) | −0.38 (−0.54 to −0.22) | ||||
CR f | 0.30 (−0.43 to 1.02) | 0.09 (−0.13 to 0.31) | .42 | ||||
Presence | 811 | −1.27 (−1.79 to −0.74) | −0.38 (−0.54 to −0.22) | ||||
Absence | 815 | −1.56 (−2.11 to −1.02) | −0.47 (−0.63 to −0.31) | ||||
AT g | 0.14 (−0.59 to 0.86) | 0.04 (−0.18 to 0.26) | .71 | ||||
Presence | 814 | −1.35 (−1.89 to −0.81) | −0.41 (−0.57 to −0.24) | ||||
Absence | 812 | −1.48 (−2.01 to −0.95) | −0.44 (−0.60 to −0.29) | ||||
PS h | −0.01 (−0.73 to 0.72) | 0 (−0.22 to 0.22) | .99 | ||||
Presence | 811 | −1.42 (−1.95 to −0.88) | −0.43 (−0.59 to −0.26) | ||||
Absence | 815 | −1.41 (−1.95 to −0.87) | −0.42 (−0.59 to −0.26) |
GAD-7: 7-item General Anxiety Disorder.
MMRM: mixed models for repeated measures.
CBT: cognitive behavioral therapy.
SM: self-monitoring.
BA: behavioral activation.
CR: cognitive restructuring.
AT: assertiveness training.
PS: problem-solving.